Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its 2024
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its 2024